Nanalysis Announces Second Quarter 2024 Conference Call
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, has announced its Second Quarter 2024 Conference Call schedule. The company will release its financial results for the quarter ended June 30, 2024, on Wednesday, August 28th, 2024. CEO Sean Krakiwsky and CFO Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results. Investors can participate via phone or through a live webcast. A separate Q&A session for European investors is scheduled for Thursday, August 29th at 8:30am ET. The webcast will be archived on the company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call.
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), un leader nelle macchine NMR portatili e nella tecnologia MRI per applicazioni industriali e di ricerca, ha annunciato il suo programma per la Conferenza Telefonica del Secondo Trimestre 2024. L'azienda pubblicherà i risultati finanziari per il trimestre terminato il 30 giugno 2024, mercoledì 28 agosto 2024. Il CEO Sean Krakiwsky e il CFO Randall McRae ospiteranno una conferenza telefonica alle 5:00 PM, ora orientale per discutere i risultati. Gli investitori possono partecipare per telefono o tramite un webcast in diretta. Una sessione di Q&A separate per gli investitori europei è programmata per giovedì 29 agosto alle 8:30 AM ET. Il webcast sarà archiviato sulla pagina delle relazioni con gli investitori dell'azienda per almeno 90 giorni e una registrazione telefonica sarà disponibile per sette giorni dopo la conferenza.
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), un líder en máquinas NMR portátiles y tecnología MRI para aplicaciones industriales e investigativas, ha anunciado su programación de la Conferencia Telefónica del Segundo Trimestre de 2024. La empresa publicará sus resultados financieros para el trimestre que terminó el 30 de junio de 2024, el miércoles 28 de agosto de 2024. El CEO Sean Krakiwsky y el CFO Randall McRae dirigirán una conferencia telefónica a las 5:00 PM, hora del Este para discutir los resultados. Los inversores podrán participar por teléfono o a través de una transmisión web en vivo. Se ha programado una sesión de preguntas y respuestas separada para inversores europeos para el jueves 29 de agosto a las 8:30 AM ET. La transmisión web se archivará en la página de relaciones con inversores de la empresa durante al menos 90 días, y una grabación telefónica estará disponible durante siete días después de la conferencia.
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)은 산업 및 연구 응용 프로그램을 위한 휴대용 NMR 기계와 MRI 기술의 선두주자로, 2024년 2분기 컨퍼런스 콜 일정을 발표했습니다. 이 회사는 2024년 6월 30일 종료된 분기의 재무 결과를 2024년 8월 28일 수요일에 발표할 예정입니다. CEO Sean Krakiwsky와 CFO Randall McRae는 동부 표준시 오후 5시에 결과를 논의하기 위해 컨퍼런스 콜을 주최합니다. 투자자들은 전화 또는 라이브 웹캐스트를 통해 참여할 수 있습니다. 유럽 투자자를 위한 별도의 Q&A 세션은 2024년 8월 29일 목요일 오전 8시 30분 ET에 예정되어 있습니다. 웹캐스트는 회사의 투자자 관계 웹페이지에 최소 90일 동안 보관되며, 컨퍼런스 콜 이후 7일간 전화 재생이 제공됩니다.
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), un leader dans les machines NMR portables et la technologie IRM pour les applications industrielles et de recherche, a annoncé son programme de conférence téléphonique pour le deuxième trimestre 2024. La société publiera ses résultats financiers pour le trimestre clos le 30 juin 2024, le mercredi 28 août 2024. Le PDG Sean Krakiwsky et le CFO Randall McRae dirigeront une conférence téléphonique à 17h00, heure de l'Est pour discuter des résultats. Les investisseurs peuvent participer par téléphone ou via un webinaire en direct. Une séance de questions-réponses distincte pour les investisseurs européens est prévue pour le jeudi 29 août à 8h30 ET. Le webinaire sera archivé sur la page des relations investisseurs de l'entreprise pendant au moins 90 jours, et une rediffusion téléphonique sera disponible pendant sept jours après la conférence téléphonique.
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), ein Führer im Bereich tragbarer NMR-Geräte und MRI-Technologie für industrielle und Forschungsanwendungen, hat seinen Konferenztermin für das zweite Quartal 2024 bekannt gegeben. Das Unternehmen wird seine finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal am Mittwoch, den 28. August 2024 veröffentlichen. CEO Sean Krakiwsky und CFO Randall McRae werden um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können per Telefon oder über einen Live-Webcast teilnehmen. Eine separate Q&A-Session für europäische Investoren ist für Donnerstag, den 29. August um 8:30 Uhr ET angesetzt. Der Webcast wird für mindestens 90 Tage auf der Investor Relations Webseite des Unternehmens archiviert, und eine telefonische Wiedergabe wird sieben Tage nach der Telefonkonferenz verfügbar sein.
- Company is maintaining transparent communication with investors through scheduled conference calls
- Nanalysis is providing separate Q&A session for European investors, indicating global market presence
- None.
Hosting Call at 5:00 pm ET on Wednesday, August 28th
European Q&A Session on Thursday August 29th at 8:30am ET
Investors interested in participating in the live full year call can dial 1-888-836-8184 or 289-819-1350 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/nwZajZWGPNR or on the investor relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-3660-6345 or 289-819-1450, conference ID # 89736.
Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Thursday, August 29th which can be accessed by the following link: Join the meeting now
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.
The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
In 2022 the Company was awarded a five-year,
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-second-quarter-2024-conference-call-302221860.html
SOURCE Nanalysis Scientific Corp.
FAQ
When will Nanalysis Scientific Corp (NSCIF) release its Q2 2024 financial results?
What time is the Q2 2024 earnings conference call for Nanalysis Scientific Corp (NSCIF)?
How can investors participate in Nanalysis Scientific Corp's (NSCIF) Q2 2024 earnings call?
When is the Q&A session for European investors of Nanalysis Scientific Corp (NSCIF)?
